International Journal of Radiation Oncology published a 10-year post-treatment analysis of the German ARO 96-02 trial. It reported that prostate cancer patients with detectable prostate specific antigen (PSA) following radical prostatectomy should receive earlier, more aggressive radiation therapy treatment. The German ARO 96-02 trial is a prospective clinical trial that compared a wait-and-see approach versus an adjuvant radiation therapy approach for patients ...
No comments:
Post a Comment